A team of physicians and scientists from the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham will present some of the latest advances in clinical cancer research to more than 32,000 oncology professionals from all over the world at the annual meeting of the American Society of Clinical Oncology in Chicago from May 31-June 4.
O’Neal Comprehensive Cancer Center investigators are authors on more than 40 abstracts accepted by ASCO for the annual meeting. With this year’s theme of Caring for Every Patient, Learning From Every Patient, UAB’s cancer experts will present about advances in targeted combination therapies for multiple myeloma, cognitive impairment after bone marrow transplantation and enhancing intervention in children with leukemia.
Scientists will also focus on many aspects of survivorship, which includes a study to help understand the cumulative burden of new onset of chronic conditions among older cancer survivors, and a novel association that induces cardiac dysfunction in childhood cancer survivors.
In addition, this year’s meeting will examine new approaches to overcoming limited access to cancer care, such as a study on the impact of travel time on health care costs and resource utilization for older patients.
Lead authors from UAB include Smita Bhatia M.D., cancer outcomes and survivorship; Luciano Costa, M.D., multiple myeloma and hematological malignancies; Kelly Kenzik, Ph.D., geriatric oncology populations; Andrew McDonald, M.D., radiation oncology; Gabrielle Rocque, M.D., breast cancer and health care costs; Purnima Singh, Ph.D., pathogenesis of treatment-related long-term complications; and Noha Sharafeldin, Ph.D., intervention strategies for cancer survivors.
Detailed information on all UAB abstracts is online; search University of Alabama at Birmingham.